BioVie
BIVI
53 hedge funds and large institutions have $8.29M invested in BioVie in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 4 reducing their positions, and 12 closing their positions.
425% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 4
280% more call options, than puts
Call options by funds: $759K | Put options by funds: $200K
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
13% more funds holding
Funds holding: 47 → 53 (+6)
0.01% more ownership
Funds ownership: 0.05% → 0.05% (+0.01%)
36% less capital invested
Capital invested by funds: $12.9M → $8.29M (-$4.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.02M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$674K |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$489K |
| 4 |
State Street
Boston,
Massachusetts
|
+$358K |
| 5 |
BlackRock
New York
|
+$329K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.56M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$833K |
| 3 |
Barclays
London,
United Kingdom
|
-$360K |
| 4 |
Squarepoint
New York
|
-$209K |
| 5 |
Jane Street
New York
|
-$208K |
BIVI Hedge Fund Activity: Q2 2023 in Review
53 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2023, worth a combined $8.29M — down 36% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BIVI positions and 12 closed out — a net gain of 6 holders — while 21 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.02M. The largest seller was Invesco, exiting entirely with an estimated $1.56M sold.
- 53 institutional investors held BioVie (BIVI) as of Q2 2023, up from 47 in Q1 2023.
- Funds reported $8.29M of BioVie stock for Q2 2023, down 36% quarter-over-quarter.
- 18 funds opened new BioVie positions in Q2 2023 and 12 closed out, a net change of +6 holders.
- The largest BioVie buyer in Q2 2023 was Millennium Management, an estimated $2.02M added.
- The largest BioVie seller in Q2 2023 was Invesco, an estimated $1.56M sold.
Based on aggregated 13F filings for Q2 2023.